Zevra Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
ZVRA chart
What traders are saying about $ZVRA
Latest postsZevra Therapeutics, Inc. news
- ZVRA Q3'26 Earnings: revenue estimate is 37.08M USD
TradingView ·
- Trading Systems Reacting to (ZVRA) Volatility
Stock Traders Daily ·
- Zevra Therapeutics, Inc. Estimates – NASDAQ:ZVRA
TradingView ·
- Zevia to Announce Third Quarter 2026 Earnings Results on November 4, 2026
Yahoo Finance ·
- Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
Yahoo Finance ·
- Zevra Therapeutics to Present at Upcoming Investor Conferences
Yahoo Finance ·
- Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium
Yahoo Finance ·
- Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- What Could Zevra Therapeutics (ZVRA) New NPC Data Mean For Its Europe Review?
Yahoo Finance ·
- Zevra Therapeutics Q2 Earnings Call Highlights
marketbeat.com ·
- Zevra Therapeutics Inc (ZVRA) (Q2 2026) Earnings Call Highlights: Revenue Surges 53% as ...
Yahoo Finance ·
- Zevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates
Yahoo Finance ·
Zevra Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $83.2M | -$105.5M | -$46.0M | -$26.8M |
| Diluted EPS | $1.35 | $-2.28 | – | – |
| Total assets (year end) | $284.7M | $178.1M | $172.3M | $115.3M |
| Cash and equivalents (year end) | $62.4M | $33.8M | $43.0M | $65.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Zevra Therapeutics, Inc.
- Ticker
- ZVRA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1434647
- Former names
- KEMPHARM, INC, KEMPHARM INC
Frequently asked questions
What exchange is Zevra Therapeutics, Inc. listed on?
Zevra Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ZVRA.
What industry is Zevra Therapeutics, Inc. in?
Zevra Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Zevra Therapeutics, Inc. headquartered?
Zevra Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Zevra Therapeutics, Inc.'s fiscal year end?
Zevra Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Zevra Therapeutics, Inc. report?
Zevra Therapeutics, Inc. reported $0 in revenue for calendar year 2015, according to its SEC filings.